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Ü1 Abstract 
Background: Specific prevalence data are needed to assess the burden of sexually 
transmitted infections (STIs) in specific settings where data are scant, such as women 
seeking early termination of pregnancy (TOP). We aimed to investigate the prevalence of 
STIs and its determinants in women at risk (e.g. pathological cervical swab) undergoing TOP 
in a primary care setting in Switzerland.  
Methods: Cross-sectional study of 620 women seeking abortion counselling at a general 
practice in Zurich, Switzerland.. Patients’ characteristics were assessed and in case of 
pathological cervical swab a PCR-based screening for Chlamydia trachomatis (CT), 
Mycoplasma genitalium (MG) and Neisseria gonorrhoeae (NG) was initiated to estimate STI 
prevalence.  Bi-and multivariable analysis were used to investigate STI determinants. 
Results: 585 out of the 620 women presenting for counselling resulted in TOP. 581 (93.7%) 
cervical specimens were available with 272 having pathological signs (46.8%), thus were 
considered at risk for STIs. In 192 screened samples 28 STIs (14.6%) (95% CI: 10.3-20.3%) 
were detected, predominantly CT (17 cases) followed by MG (9 cases) and NG (2 cases). 
Compared to non-immigrants, immigrants were more likely to have a STI (adjusted OR 2.63; 
p=0.037) Non-screened women were significantly more often self-payers (31.3%) compared 
to screened women (8.3%) (p<0.001). 
Conclusion: We found a high STI prevalence in women presenting for TOP in a Swiss 
primary care setting. Women with a migration background seemed to be a vulnerable 
subgroup. Public health efforts are needed to implement cost-effective screening and case 
management programs in this population at risk for STIs.  
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Ü1 Abbreviations 
CT: Chlamydia trachomatis 
MG: Mycoplasma genitalium 
NG: Neisseria gonorrhoeae 
STI: Sexually transmitted infection 
TOP: Termination of pregnancy 
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Ü1 Introduction 
Sexually transmitted infections (STI) are among the most common causes of illness in the 
world and have far-reaching health, social and economic consequences for many countries. 
Chlamydia trachomatis (CT), Mycoplasma genitalium (MG) and Neisseria gonorrhoeae (NG) 
are considered being common sexually transmitted pathogens and can cause genitourinary 
infections with a wide range of symptoms; in women MG and NG can cause cervicitis, 
urethritis and endometritis (1-5). The causal connection of MG with salpingitis as well as 
potentially resulting infertility remains controversial, whereas CT and NG are known to cause 
salpingitis and have an impact on infertility (1, 4, 6-10). An untreated CT infection can also 
lead to peritonitis, perihepatitis, pelvic inflammatory disease (PID) and ectopic pregnancy 
(EP) (4, 6, 7). Genital CT and NG infections are asymptomatic or just show mild symptoms in 
up to 70% and 50% of cases, respectively (4, 11). As a consequence, these infections often 
remain undetected thus abetting further transmission. Similarly, asymptomatic MG infections 
have also been described, raising the question whether also asymptomatic subgroups, such 
as women presenting for early termination of pregnancy (TOP), should be screened for MG 
(12, 13). 
International prevalence rates of STIs vary, depending on the study setting. A population-
based Danish screening program with subjects aged 21 to 23 years in 1997-98 assessed CT 
and MG prevalence rates of 8.4% and 2.3% in women, respectively (14). Data on the 
prevalence of NG infection in the general population do not seem to exist. Studies based on 
females undergoing TOP in a hospital setting mentioned infection rates as follows: CT 2.8% 
to 15.74%; MG 0.98% to 8.7%; NG 0.67% to 3% (12, 15-18). Reasons for these wide ranges 
are multifarious, e.g. different detection techniques, differences in socio-demographics. A 
study from the UK reported CT prevalence rates in pregnancy termination clinics more than 
twice as often than in the general population, suggesting TOP to be a risk for STIs (19). 
Beyond the number of sexual partners, an established risk factor for STIs, results for age and 
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migration background as potential risk factors for STIs in women seeking pregnancy testing 
and TOP are controversial (15, 20, 21). 
In Switzerland TOP is also provided by general practitioners in a primary care setting (22). 
Whereas data on STI prevalence in women seeking for TOP are mainly derived from studies 
in specialized secondary care settings (e.g. hospital settings), data from the primary care 
setting, especially from Switzerland, are scant. We aimed to estimate STI prevalence rates of 
CT, MG and NG in women seeking TOP in a primary care setting in Switzerland. 
Furthermore we investigated potential determinants for STIs among this population. 
 
Ü1 Methods 
We performed a retrospective analysis of patients presenting for TOP in a single-handed 
general practice from 01.01.2006 to 10.03.2009. After receiving counseling for induced 
abortion patients were asked for their informed consent to participate in an anonymous data 
analysis along with the written request for TOP. Since data were anonymised by the 
attending physician before analysis, the study did not require a formal ethics approval 
according to Swiss ethics guidelines. 
 
Ü2 Setting and Data collection 
The data was collected by the general practice located in the centre of Zurich, Switzerland 
(population approximately 400.000). The physician has extensive experience in medication 
and aspiration abortion as an outpatient treatment and provides standard medical services in 
addition.  
Legal TOP up to the 12th pregnancy week is at the women’s own discretion (beyond the 12th 
week a medical attest is needed) and reimbursed by the mandatory health insurance. 
However direct payment related to high deductibles are possible. 
Anonymised patients’ characteristics were entered into an Excel-Sheet including following 
parameters: patients age, first consultations date, estimated pregnancy age, origin/ethnicity, 
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numbers of gravidities and deliveries, numbers of TOP and their procedures, date of TOP, 
date of follow-up visit, date of re-aspiration in case of incomplete abortion and method of 
payment. Positive migration status was defined in case of immigration in the first generation.  
Ü2 Diagnostic and treatment procedures 
Females presenting for abortion were counseled and carefully examined by the same 
physician. After gynecological exploration a cervical specimen was taken. Additionally a first 
void urine analysis was conducted with a urine test strip. In the case of a pathological 
cervical swab (defined as elevated number of leucocytes per high power microscope field) a 
PCR screening for CT, MG and NG was initiated out of the cervical swab, whenever the 
patient agreed. 
Antibiotic prophylaxis (Metronidazol 2×500mg vaginally and Azithromycin 1x1g perorally) as 
recommended by current guidelines was routinely administered in all women undergoing 
TOP (23) . 
To confirm an actual pregnancy a qualitative β-HCG (human chorionic gonadotropin 
hormone) urine assay was conducted. To determine the gestational age a transvaginal 
ultrasound was performed. The patients were informed on the procedures, alternatives and 
risks recommended by the Swiss Society for Gynecology and Obstetrics (24). 
For pharmacological abortion the woman took 200 mg mifepristone orally followed by 
vaginally administered misoprostol 400mcg  36-48 hours later. In the three-week follow-up 
visit the complete abortion was confirmed with ultrasound and if necessary β-HCG serum 
levels were assessed. 
For aspiration abortion 400mcg of misoprostol were administered vaginally at least two hours 
before the intervention. Mostly a follow-up was performed 3-10 days after the intervention. 
 
Ü2 Primary and secondary outcomes 
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Primary outcome: prevalence of STIs in women undergoing TOP in a primary care setting, 
defined as the proportion of women with a  pathological cervical swab resulting in a positive 
PCR screening test (CT, MG or NG). 
Secondary outcome: patient characteristics associated with a sexually transmitted pathogen. 
 
Ü2 Statistical analysis  
Descriptive statistics were calculated for all variables and presented as means (SD) and 
proportions. Bivariate comparisons between women with and without a STI were performed 
using unpaired t-tests and pearson’s chi-squared test statistics accordingly. To further 
assess the independent association between a positive screening result for STI and patients’ 
characteristics we applied multiple logistic regression analysis.Two-sided p-values <0.05 
were considered as statistically significant. All statistical analyses were performed with 
STATA, version 11.2 (Stata Incorporation, College Station, TX, USA). 
 
Ü3 Results 
Ü2 Patient Characteristics 
During the study period, 620 women were seeking for abortion counselling at the general 
practice. Detailed patient characteristics are listed in Table 1. Patients mean (SD) age was 
29.4 (6.9) years. The study population consisted of 49.7% patients with migration 
background. Most of the women were nulliparous (63.4%) and the majority (75%) never had 
a TOP before. The proportion of women who previously had a TOP was significantly higher 
in women with migration background (32.5% vs. 17.7%, p<0.001). In 585 women (94.4%) the 
counselling resulted in TOP. Among the other 5.6% the main reason not to proceed with a 
TOP was the decision to carry the child to term (40%). In 64.4% (n=377) the abortions were 
performed medically, in 35.6% by curettage. The mean estimated gestational age was 7.0 
weeks (SD 1.7) at the time of abortion counselling.  
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Ü2 Prevalence of STI 
As seen in Figure 1, from the 585 women who underwent a TOP, 581 (99.3%) cervical swab 
specimens were available for further analysis: 272 (46.8%) of the cervical swabs showed 
pathological signs. In 192 contacts (70.6% of cases with  pathological cervical swab) PCR 
screening was performed. In 28 cases an STI was detected, corresponding to a prevalence 
(95%-CI) of 14.6% (10.3-20.3). In 5 (1.6%) cases with normal cervical swab specimens a 
PCR was performed, all of which were negative. The reasons for performing these PCR 
varied (patient’s request, prior STI history, and promiscuous behaviour). STI-specific 
frequencies for CT, MG, and NG were as followed: 17 (8.9%), 9 (4.7%), and 2 (1.04%). One 
woman showed a double infection with CT and MG. 
 
Ü2 Comparisons between women with and without STI 
Detailed bivariate group comparisons are presented in Table 2. Patients with a positive STI 
screening were significantly more likely to have a migration background compared to women 
with Swiss origin (66.7% vs. 33.3%; p=0.044). Women with a positive CT test were 
significantly younger compared to their non-infected counterparts (25.6 vs. 29.6; p=0.03). 
Migrants showed a tendency in having CT infections more often when compared to non-
migrants (70.6% vs. 29.4%; p=0.055.). The number of previous TOP was significantly higher 
in women with a detection of MG compared to MG negative women (0.78 vs. 0.3; p=0.039). 
Due to the small number of NG infections we did not perform additional subgroup analyses. 
In the multivariable analysis (Table 3) we further assessed the independent association 
between a positive screening result for STI and patients’ characteristics. Patient 
determinants showinga bivariate association with a STI detection (defined as a p-value <0.1 
in Table 2) were included in the regression model. In addition results of the urine analyses 
(e.g. occurrence of protein, leucocytes or erythrocytes) and mode of payment of TOP were 
included as potential confounders. A migration background remained significantly associated 
with a positive STI screening test with an OR of 2.63 (p=0.037) compared to women with a 
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Swiss origin, when controlled for age, number of TOP in the past, pathological urine analyses 
and mode of payment of the TOP. 
 
Ü2 Determinants for screening 
In the case of a  pathological cervical swab the proposed PCR based screening for STIs was 
at the patient’s own discretion, thus prevalence estimates can be biased due to a selection. 
Screened and non-screened women having a  pathological cervical swab, did not differ with 
regard to age (p=0.47) and number of TOP in the past (p=0.73) . In 25 out of the 80 non-
screened women (31.3%) medical costs of the TOP were directly paid by the patients 
themselves. In screened women the proportion of women who directly paid the medical costs 
only reached 8.9% (17 out of 192 patients) (p<0.001). Women with migration background 
were significantly more often self-payers (24.7%) compared to non-immigrants (9.6%) 
(p<0.001). There was a tendency of slightly higher screening rates in patients without 
migration background compared to patients with migration background (75.4% vs. 66.0%; 
p=0.089).  
 
Ü1 Discussion  
In our study on 585 women who had first trimester TOP in a primary care setting nearly half 
were considered at increased risk for STI due to a  pathological cervical swab and thus were 
offered a PCR screening for common STI pathogens. In this setting STI prevalence of 14.6 
% was observed. Migration background was significantly associated with the detection of  
STI. 
Our STI prevalence is comparable with a study from Denmark, which involved patients 
requesting an abortion in a hospital setting (15). In this study an STI prevalence (without NG) 
of 16.7% was detected. Another hospital based study with women presenting for TOP in New 
Zealand, which only analyzed patients below 25 years, reported a higher STI prevalence of 
25.1% with a CT prevalence of 15.7%  and a NG prevalence below 1% (12). The majority of 
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STIs in our study population was caused by CT infection resulting in a CT prevalence of 9%, 
being lower than the prevalence found in Denmark and in New Zealand, both reporting a CT 
prevalence around 15%. Our 4.7% prevalence of MG infections lies in between the study 
from New Zealand and Denmark with prevalence ranging between 8.7% and 0.98%. 
STI prevalence estimates from primary care settings providing TOP, especially from 
Switzerland, are scant thus we were not able to compare our results in a similar setting. Our 
prevalence rates were clearly higher compared to a representative population-based sample 
of young adults in the United States reporting a prevalence of MG, CT, and NG of 1.0%, 
4.2%, and 0.4%, respectively (25). Our findings seemed to be more similar to a secondary or 
specialized care setting compared to a population-based setting, probably reflecting the fact 
that an unintended pregnancy might be related to sexual risk behavior and the possibility of 
exposure to sexually transmitted pathogens. We found a higher CT prevalence compared to 
women aged less than 35 years having a first consultation for pregnancy with their 
gynecologist in Switzerland, reporting a CT prevalence of 1.3% (26) further indicating that 
TOP might be a risk factor for STI. However STI prevalence comparisons even in the same 
health care setting have to be handled with caution. Williams et al. (27) found different 
prevalence rates and risk factors of CT infections in women attending two sexual and 
reproductive health clinics in Melbourne, Australia, pointing out that prevalence and 
identifiable risk factors are not transferable between population even in the same city.  
 
Our multivariable analysis was associated with a significant 2.6 times higher overall STI 
detection rate in women with migration background compared to women with Swiss origin. 
This difference in overall STI was mainly related to the most prevalent STI, namely CT 
infection, showing a prevalence of 13.04 % in women with migration background compared 
to a CT prevalence of 5.1% in women without migration background. These numbers are 
consistent with Wolff et al. (20) analyzing prevalence of CT infection in women requesting 
TOP in a Swiss university hospital. In this study undocumented migrants were nearly three 
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times more likely to be infected with CT than their controls with legal residency permits 
(12.8% vs. 4.4%). 
In  the bivariate analysis of our study younger age was significantly associated with a positive 
CT result; inon average patients with CT infection were four years younger than patients 
without CT infection. Findings in literature on the association of CT infection with age are not 
consistent. The above mentioned Danish study (15), involving women requesting an abortion 
in a hospital setting, showed a higher CT prevalence in the younger age group (18-24 years) 
compared to the age group older than 24 years, with the difference not reaching statistical 
significance. In women of younger agegroup however bacterial load was significantly higher. 
In contrast, a survey from family-planning clinics in South Carolina (21), including women 
seeking for pregnancy testing, identified younger age as a significant predictor of CT 
infection in multivariate analysis (additionally controlled for patient characteristics such as 
race and pregnancy). Age as a risk factor for CT infection has been found in populations with 
higher prevalence rates (27, 28), indicating that differences in prevalence rates might 
influence and/or explain different study findings. This observation is in line with a Swiss study 
evaluating the CT prevalence in a low-risk population consisting of sexually active women 
aged less than 35 years having a routine check-up with their gynecologist. Among these 
women a CT prevalence of 2.8% has been observed with no difference between age groups 
(26). A higher number of induced abortions in the past was a significant determinant for the 
detection of an MG infection in bivariate analysis. In contrast Lawton and colleagues (12) did 
not find an association between MG infections and number of abortions in women seeking 
for TOP in New Zealand. In this study MG prevalence was higher (8.7%) compared to our 
study population (4.7%). The fact that we could not detect a significant association which 
persisted in the multivariate analysis might suggest confounding as a potential explanation 
for the significant results from our bivariate findings. Further research is needed to elucidate 
potential risk factors for MG infections. 
H 
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Ü2 Strengths and limitations 
The current data analysis was based on a single-handed general practice, thus 
representativeness of the results could be questioned. Our patient population shows similar 
characteristics compared to the whole population seeking TOP in Switzerland during the 
study period with regard to age, TOP method used (e.g. medical vs. surgical) and gestational 
age (29). Although patient characteristics compare favourably with the general TOP 
population in Switzerland, caution in necessary concerning the generalization with respect to 
STI prevalence estimates. Different Settings  (e.g. private practice, hospitals) have to be 
taken into consideration as well as different locations (e.g. urban, suburban), which have 
shown to affect prevalence rates (27). A limitation of our study is that in 29.4% of cases with 
a  pathological cervical swab a PCR was not performed, thus our prevalence estimates are 
prone to a selection bias. Screened and non-screened women having a  pathological cervical 
swab did not differ with regard to age and number of induced abortions in the past. However 
non-screened females consisted of significantly more self-payers and showed a trend for  
migration background. We hypothesised that self-payers have higher deductibles in order to 
reduce health insurance premium and thus are more sensitive to extra costs related with 
laboratory analysis. Furthermore the fact that non-screened women tended to have a 
migration background is in line with a former Swiss Health Survey study that found a lower 
uptake of breast cancer screening measures in immigrant women compared to Swiss 
nationals (30). The fact that STI detection was independently associated with a migration 
background supports the hypothesis that our observed prevalence rates might be 
underestimated. 
CT screening is recommended for all pregnant women by the Center for Disease Control 
(CDC) (1), whereas the US Preventive Services Task Force (USPSTF) recommends 
screening in all pregnant women aged 24 years or younger and in older pregnant women 
who are at increased risk (31). Our results provide further evidence that women seeking TOP 
in a primary care setting in Switzerland have a high STI prevalence and efforts to implement 
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screening strategies followed by an efficient case management and contact tracing service 
(e.g. identification and treatment of sexual partners) are warranted. This is in contrast to the 
latest report on CT control activities in Europe that did not find an organised activity for 
Switzerland (32). 
To our knowledge this is the first study that analyzed STI prevalence (e.g. CT, MG, NG) in 
women presenting for TOP in a Swiss primary care setting. We found an overall high 
prevalence with CT infection as the most commonly detected one. In addition migration 
background was independently associated with the detection of STI. Further research is 
needed focusing on cost-effective screening and case management programs in this 
population at risk. Finally public health activities are necessary to implement evidence-based 
recommendations.  
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Table 1: Characteristics of women seeking for abortion counselling 
 N* (%) or mean (SD) 
Age (years) 29.4 (6.9) 
Migration background  308 (49.7) 
Nulliparous  393 (63.4) 
Previous induced abortions: 
0 
1 
 2 
 3 
>3 
 
465 (75.0) 
121 (19.5) 
20 (3.2) 
9 (1.5) 
5 (0.8) 
Induced abortion following counselling by the GP  585 (94.4) 
Medical pregnancy termination 377 (60.8) 
Estimated gestational age (week) 7.0 (1.7) 
Reasons not to proceed with pregnancy termination (n=35) 
  Carry the child to term 
  Sspontaneous early pregnancy loss 
  Breaking off the contact 
  Abortion preferred elsewhere 
  No pregnancy 
  Ectopic pregnancy 
  Blighted ovum 
 
14 (40) 
8 (22.9) 
5 (14.3) 
3 (8.6) 
2 (5.7) 
2 (5.7) 
1 (2.9) 
* N=620 women seeking for counselling at the primary care practice from 01-01-2006 to 10-03-
2009 
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Table 2: Bivariate Comparison of  characteristics between women with a pathological cervical 
swab with and without STI detection before early pregnancy abortion (N=192) 
Determinants Positive STI 
screening 
 
Negative STI 
screening 
 
P-value for group 
comparison #  
Any positive STI screening     
Mean age (years) 28.1 (7.2) 29.4 (7.0) 0.40 
Migration background     
- Yes % (N)  66.7 (18) 45.7 (75)  
- No % (N) 33.3 (9) 54.3 (89) 0.044 
Mean number of TOP in the past (SD) 0.44 (0.64) 0.31 (0.68) 0.33 
Mode of payment     
- Self % (N) 3.7 (1) 9.7(16)  
- Insurance % (N) 96.3 (26) 90.3 (149) 0.48 
Positive C. trachomatis screening     
Mean age (years) (SD) 25.6 (6.4) 29.6 (7.1) 0.036 
Migration background     
- Yes % (N) 70.6 (12) 46.2 (80)  
- No % (N) 29.4 (5) 53.8 (93) 0.055 
Mean number of TOP in the past (SD) 0.29 (0.59) 0.33 (0.68) 0.845 
Mode of payment     
- Self % (N) 0 9.8 (17)  
- Insurance % (N) 100 (17) 90.2 (157) 0.371 
Positive M. genitalium screening     
Mean age (years) (SD) 31.8 (7.56) 29.1 (7.06) 0.262 
Migration background     
- Yes % (n) 55.6 (5) 48.3 (87)  
- No % (n) 44.4 (4) 51.7 (93) 0.742 
Mean number of TOP in the past (SD) 0.78 (0.67) 0.30 (0.67) 0.039 
Mode of payment     
- Self % (N) 11.1 (1) 8.8 (16)  
- Insurance % (N) 88.9 (8) 91.2 (165) 0.578 
Figures represent mean (SD) or % (N); N=Maximum sample size 192, differences reflect missing 
information in patient characteristics; # Group comparisons by Chi-squared or Fisher exact test for 
categorical variables as appropriate and t-tests for continuous variables. 
TOP: Termination of pregnancy 
STI: Sexually transmitted infection  
 
 
18 
  
 
Table 3: Adjusted association between a positive STI screening and migration background 
 Odds Ratio 95%-CI p-value 
Model 1    
Migration background 
- Reference=No 
2.34 
1.00 
0.98-5.61 
- 
0.057 
- 
Model 2    
Migration background 
- Reference=No 
2.63 
1.00 
1.06-6.54 
- 
0.037 
- 
Model 1: Odds ratio controlled for age, number of induced abortions and mode of TOP payment 
(self/insurance) 
Model 2: Odds ratio based on model 1 and additionally controlled for pathological first void urine 
(yes/no) 
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Figure legend 
Study flow of patients seeking for early pregnancy abortion counselling. Out of 585 women 
proceeding for induced abortion 272 women were considered at risk for STI due to 
pathological cervical swab, thus a PCR screening for M. genitalium, C. trachomatis, and N. 
gonorrhoeae was recommended. A total of 28 STIs were detected in 192 screening samples 
resulting in a prevalence (95%-CI) in this population at risk of 14.6% (10.3-20.3). 
 
 
20 

